1-8 of 8
Amy Chen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Biological Characterization and Differential Gene Expression Analysis of CYT-338 NK Cell Engager (NKE) Against CD38 Expressing Tumors Including Multiple Myeloma (MM)

Liang Lin, Hao-Ming Chang, Dennis Wu, Ben Titz, Amy Chen, Marshall Chao Ma, Preeti Ashok, David Zou, Nejmi Dilmac, Armand Bensussan, Jean Kadouche, Chorom Pak, Stanley Frankel, Daniel Teper, Wei Li, Antonio Arulanandam
Journal: Blood
Blood (2022) 140 (Supplement 1): 7068–7069.
https://doi.org/10.1182/blood-2022-170193
Published: 2022
Journal Articles

ALX148 Enhances the Depth and Durability of Response to Multiple AML Therapies

Amy Chen, Ons Harrabi, Abraham P Fong, MDPhD, Katherine L. Ruffner, MD, Alison J. Forgie, PhD, Janet Sim, PhD, Sophia S Randolph, MDPhD, Hong Wan, PhD, Jaume Pons, PhD, Tracy C Kuo, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-137112
Published: 2020
Journal Articles

ALX148 Is a High Affinity Sirpα Fusion Protein That Blocks CD47, Enhances the Activity of Anti-Cancer Antibodies and Checkpoint Inhibitors, and Has a Favorable Safety Profile in Preclinical Models

Steven E Kauder, PhD, Tracy C Kuo, PhD, Amy Chen, Ons Harrabi, Sony S Rocha, Laura Doyle, Sangeetha Bollini, Bora Han, PhD, Emma Ruth B Sangalang, Janet Sim, PhD, Sophia Randolph, MDPhD, Jaume Pons, PhD, Hong I Wan, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 112.
https://doi.org/10.1182/blood.V130.Suppl_1.112.112
Published: 2017
Journal Articles

Preclinical Evaluation of Allogeneic Anti-Bcma Chimeric Antigen Receptor T Cells with Safety Switch Domains and Lymphodepletion Resistance for the Treatment of Multiple Myeloma

Bijan Boldajipour, PhD, Roman Galetto, PhD, Cesar Sommer, PhD, Thomas Pertel, PhD, Julien Valton, PhD, Yoon Park, PhD, Annabelle Gariboldi, Amy Chen, Tao Geng, Hong H Dong, Gregory R Boucher, Thomas J Van Blarcom, PhD, Javier Chaparro-Riggers, PhD, Arvind Rajpal, PhD, Julianne Smith, PhD, Tracy Kuo, PhD, Barbra Sasu, PhD
Journal: Blood
Blood (2016) 128 (22): 381.
https://doi.org/10.1182/blood.V128.22.381.381
Published: 2016
Journal Articles

Preclinical Evaluation of a Potent Anti-Bcma CD3 Bispecific Molecule for the Treatment of Multiple Myeloma

Siler H Panowski, PhD, Tracy Kuo, PhD, Amy Chen, Tao Geng, Thomas J Van Blarcom, PhD, Kevin Lindquist, PhD, Wei Chen, Javier Chaparro-Riggers, PhD, Barbra Sasu, PhD
Journal: Blood
Blood (2016) 128 (22): 383.
https://doi.org/10.1182/blood.V128.22.383.383
Published: 2016
Journal Articles

Disparities in the Use of Chemo-Immunotherapy for Diffuse Large B-Cell Lymphoma in the United States.

Christopher R. Flowers, MD, Stacey Fedewa, MPH, Amy Chen, MD, MPH, FACS, Joseph Lipscomb, PhD, Otis Brawley, MD, Elizabeth Ward, PhD
Journal: Blood
Blood (2009) 114 (22): 897.
https://doi.org/10.1182/blood.V114.22.897.897
Published: 2009
Journal Articles

Cbfb-MYH11 Induces Expansion of a Lin-Kit+Sca1- Abnormal Progenitor Compartment that Predisposes Acute Myeloid Leukemia in Mice.

Ya-Huei Kuo, Susan Heilman, Amy Chen, Pu P. Liu, Rachel Gernstein, Scott Kogan, Lucio H. Castilla
Journal: Blood
Blood (2004) 104 (11): 543.
https://doi.org/10.1182/blood.V104.11.543.543
Published: 2004
Journal Articles

Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11

Mondira Kundu, Amy Chen, Stacie Anderson, Martha Kirby, LiPing Xu, Lucio H. Castilla, David Bodine, Pu Paul Liu
Journal: Blood
Blood (2002) 100 (7): 2449–2456.
https://doi.org/10.1182/blood-2002-04-1064
Published: 2002